These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 9514864)
21. Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines. Lehmann J; Retz M; Sidhu SS; Suttmann H; Sell M; Paulsen F; Harder J; Unteregger G; Stöckle M Eur Urol; 2006 Jul; 50(1):141-7. PubMed ID: 16476519 [TBL] [Abstract][Full Text] [Related]
22. Investigating the effects of positive charge and hydrophobicity on the cell selectivity, mechanism of action and anti-inflammatory activity of a Trp-rich antimicrobial peptide indolicidin. Nan YH; Park KH; Park Y; Jeon YJ; Kim Y; Park IS; Hahm KS; Shin SY FEMS Microbiol Lett; 2009 Mar; 292(1):134-40. PubMed ID: 19191872 [TBL] [Abstract][Full Text] [Related]
23. Structural contributions to the intracellular targeting strategies of antimicrobial peptides. Lan Y; Ye Y; Kozlowska J; Lam JK; Drake AF; Mason AJ Biochim Biophys Acta; 2010 Oct; 1798(10):1934-43. PubMed ID: 20637722 [TBL] [Abstract][Full Text] [Related]
24. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Song YM; Park Y; Lim SS; Yang ST; Woo ER; Park IS; Lee JS; Kim JI; Hahm KS; Kim Y; Shin SY Biochemistry; 2005 Sep; 44(36):12094-106. PubMed ID: 16142907 [TBL] [Abstract][Full Text] [Related]
25. Membrane pores induced by magainin. Ludtke SJ; He K; Heller WT; Harroun TA; Yang L; Huang HW Biochemistry; 1996 Oct; 35(43):13723-8. PubMed ID: 8901513 [TBL] [Abstract][Full Text] [Related]
26. Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli. Mangoni ML; Papo N; Barra D; Simmaco M; Bozzi A; Di Giulio A; Rinaldi AC Biochem J; 2004 Jun; 380(Pt 3):859-65. PubMed ID: 15032749 [TBL] [Abstract][Full Text] [Related]
27. Oleoyl-chitosan nanoparticles inhibits Escherichia coli and Staphylococcus aureus by damaging the cell membrane and putative binding to extracellular or intracellular targets. Xing K; Chen XG; Liu CS; Cha DS; Park HJ Int J Food Microbiol; 2009 Jun; 132(2-3):127-33. PubMed ID: 19439383 [TBL] [Abstract][Full Text] [Related]
28. A peptide fragment derived from the T-cell antigen receptor protein alpha-chain adopts beta-sheet structure and shows potent antimicrobial activity. Zhang G; Lin X; Long Y; Wang Y; Zhang Y; Mi H; Yan H Peptides; 2009 Apr; 30(4):647-53. PubMed ID: 19111845 [TBL] [Abstract][Full Text] [Related]
29. The antimicrobial peptide polyphemusin localizes to the cytoplasm of Escherichia coli following treatment. Powers JP; Martin MM; Goosney DL; Hancock RE Antimicrob Agents Chemother; 2006 Apr; 50(4):1522-4. PubMed ID: 16569873 [TBL] [Abstract][Full Text] [Related]
30. Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes. Takeshima K; Chikushi A; Lee KK; Yonehara S; Matsuzaki K J Biol Chem; 2003 Jan; 278(2):1310-5. PubMed ID: 12417587 [TBL] [Abstract][Full Text] [Related]
31. Expression of the cationic antimicrobial peptide lactoferricin fused with the anionic peptide in Escherichia coli. Kim HK; Chun DS; Kim JS; Yun CH; Lee JH; Hong SK; Kang DK Appl Microbiol Biotechnol; 2006 Sep; 72(2):330-8. PubMed ID: 16421719 [TBL] [Abstract][Full Text] [Related]
32. Investigating the nucleic acid interactions and antimicrobial mechanism of buforin II. Uyterhoeven ET; Butler CH; Ko D; Elmore DE FEBS Lett; 2008 May; 582(12):1715-8. PubMed ID: 18448075 [TBL] [Abstract][Full Text] [Related]
33. Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis. Ulvatne H; Samuelsen Ø; Haukland HH; Krämer M; Vorland LH FEMS Microbiol Lett; 2004 Aug; 237(2):377-84. PubMed ID: 15321686 [TBL] [Abstract][Full Text] [Related]
34. Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide. Lee HS; Park CB; Kim JM; Jang SA; Park IY; Kim MS; Cho JH; Kim SC Cancer Lett; 2008 Nov; 271(1):47-55. PubMed ID: 18617323 [TBL] [Abstract][Full Text] [Related]
35. Interaction of a magainin-PGLa hybrid peptide with membranes: insight into the mechanism of synergism. Nishida M; Imura Y; Yamamoto M; Kobayashi S; Yano Y; Matsuzaki K Biochemistry; 2007 Dec; 46(49):14284-90. PubMed ID: 18004888 [TBL] [Abstract][Full Text] [Related]
36. Binding of antibacterial magainin peptides to electrically neutral membranes: thermodynamics and structure. Wieprecht T; Beyermann M; Seelig J Biochemistry; 1999 Aug; 38(32):10377-87. PubMed ID: 10441132 [TBL] [Abstract][Full Text] [Related]
37. The intracellular mechanism of action on Escherichia coli of BF2-A/C, two analogues of the antimicrobial peptide Buforin 2. Hao G; Shi YH; Tang YL; Le GW J Microbiol; 2013 Apr; 51(2):200-6. PubMed ID: 23625221 [TBL] [Abstract][Full Text] [Related]
38. Esculentin-1b(1-18)--a membrane-active antimicrobial peptide that synergizes with antibiotics and modifies the expression level of a limited number of proteins in Escherichia coli. Marcellini L; Borro M; Gentile G; Rinaldi AC; Stella L; Aimola P; Barra D; Mangoni ML FEBS J; 2009 Oct; 276(19):5647-64. PubMed ID: 19725877 [TBL] [Abstract][Full Text] [Related]
39. Antimicrobial activity and protease stability of peptides containing fluorinated amino acids. Meng H; Kumar K J Am Chem Soc; 2007 Dec; 129(50):15615-22. PubMed ID: 18041836 [TBL] [Abstract][Full Text] [Related]
40. [The action mechanism of analogues of the antimicrobial peptide Buforin II with E. coli genomic DNA]. Hao G; Shi Y; Tang Y; Le G Wei Sheng Wu Xue Bao; 2010 Mar; 50(3):328-33. PubMed ID: 20499637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]